Furthermore, neoantigens are displayed by both HLA-I and HLA-II molecules, and neoantigen-reactive CD4+ T cells are likely to play an indispensable role in T cell–mediated tumor rejection in vivo (26–30). Here, CD4 is linked to neoplasm.